The reason the extremely high rates of HIV infection in women are not declining compared to men, is because more conscientious treatment-and-care behaviors of women has begun to protect men from acquiring HIV, according to South African researchers at the recent Conference on Retroviruses and Opportunistic Infections (CROI 2018).
Alain Vandormael of the University of KwaZulu-Natal and the Africa Health Research Institute (AHRI), Mtubatuba, said that getting more, and younger, men on to HIV treatment was essential in order to reduce the persistently high HIV incidence in young women, especially if combined with prevention measures that offer women the same degree of protection as medical male circumcision does to men.
Vandormael was presenting the most recent findings from a long-lasting cohort study in north-eastern KwaZulu-Natal conducted by the AHRI. It was this cohort that in 2012 provided the first evidence from a low-income setting that getting a sufficiently high proportion of the population virally suppressed was starting to bring down the HIV infection rate.
Because this area has comprehensive HIV surveillance, part of it was also chosen to host ANRS 12249, the world’s first study of the population-level effects of “Test and Treat” as a strategy.
In the AHRI cohort, people are proactively tested by community health workers, who visit each household in the catchment area, using dried blood spot technology, once a year. Between 2004 and 2015, 38,597 people have been tested for HIV at least once and exactly 17,400 testers (45%), whose first test was HIV negative and who have taken at least one more HIV test since then, form the “incidence cohort”. Of these, 9908 (57%) are women.
Among men, there have been 641 new diagnoses of HIV in 28,006 person-years (overall annual incidence, 2.3%) and in women, 1915 in 40,182 person-years (4.8%). HIV incidence was not only lower in men than in women generally, it also declined from 2.4% in 2005 to 2.05% in 2010 and then to 0.95% in 2015. From 2010 onwards this fall was statistically significant.
In contrast HIV incidence in women during the same period increased, from 4.2% it 2005 to 4.65% in 2010 and then 5.1% in 2015. This nearly reaches statistical significance. There are signs of a levelling-off in the incidence rate from 2013 to 2015, but not a decline.
Why, among a population that has seen antiretroviral therapy (ART) coverage of those in care rise by over 60% in the last five years, have men seen their rate of HIV infection fall by over half, while among women there has been an increase?
One explanation has been that age differences are partly to blame. It is certainly true that HIV annual HIV incidence is still disproportionately high among young women: currently 5.4% of girls aged 15-20 are infected with HIV per year, 7% aged 20-25 and 6% aged 30-35. By the time women are 30, a huge proportion of them have HIV – more than half in some areas.
Annual HIV incidence in men, on the other hand, is very low in youth – just 0.7% in boys aged 15-20 – and does not start to exceed that in women until the ages of 35-40, when it is 3% in men and 2.2% in women.
However, the researchers did not believe age-mixing was entirely the reason for the much higher rates in young women. They also thought it might, in recent years, have to do with the fact that more women than men are on treatment. Women are tested for HIV earlier – often in an antenatal setting – and are put on ART earlier.
Between 2010 and 2015 the proportion of women with HIV who were on treatment – including those not in regular care – increased by 66% from 29% to 49%. Among men, however, it only increased from 26% to 38% – a 46% increase.
Did the increase in the number of people on ART have a population-level effect on the overall infectiousness of the HIV-positive population? Among women, yes it did. The best way to evaluate this is to estimate the proportion of the entire population who have a detectable viral load, not just those who are known to have HIV.
In women, the proportion of the entire population with a detectable viral load did decline between 2011 and 2014, from 21.5% to 19.5%. This might not look a lot in absolute terms but does represent a 9.3% decline. In men, on the other hand the proportion with a detectable viral load actually increased during these three years from 14% to 17% – a 21% increase.
In other words, while age mixing is part of the explanation, another part is simply that young women are much more likely to be diagnosed and on HIV treatment than young men – and although in absolute terms fewer men have HIV, a higher proportion of them are infectious.
During this period the proportion of men who were circumcised also grew and though Vandormael did not give figures for this, in a study from KwaZulu-Natal last year, while 51% of youth aged 15-19 were circumcised, less than 20% of men aged over 35 were. This may partly explain the big differential between female and male HIV infection rates in younger people.
Vandormael said that to reduce the still exceptional rates of HIV infection in young women, two things needed to happen. Firstly, men, and especially young men, not only needed to be tested regularly for HIV but also better linked to care and treatment. And secondly, women badly needed an equivalent to medical male circumcision for HIV prevention. The vaginal ring, while not lifelong in its effect, might represent such an opportunity, Vandormael said.
The extraordinary scale-up of antiretroviral therapy (ART) is expected to reduce the rate of new HIV infections at the population level. In this study, we calculated the incidence of HIV for males and females using data from a complete South African population.
The Africa Health Research Institute (AHRI) maintains an annual HIV surveillance system in the Umkhanyakude district of the KwaZulu-Natal province. Between 2004 and 2015, we followed 6,287 males (aged 15–54 years) and 8,661 females (aged 15–49 years) from their earliest HIV-negative test date until their latest HIV-negative or earliest HIV-positive test date. In addition, we obtained viral load measurements from all HIV-positive participants in 2011, 2012, and 2014 and included ART initiation data from the 17 health-care clinics in the AHRI surveillance area.
The HIV incidence rate declined among males aged 15–25 years between 2012 and 2015, from 1.70 (95% CI: 1.13–2.26) to 0.60 (95% CI: 0.00–1.29) events/100 person-years, as well as for males aged 25–54 years, from 3.28 (95% CI: 1.97–4.55) to 1.87 (95% CI: 0.60–3.56) events/100 person-years. For females aged 15–25 years, however, the HIV incidence rate increased from 6.32 (95% CI: 5.34–7.32) to 6.67 (95% CI: 5.25–8.16) events/100 person-years between 2013 and 2015. Throughout the study period, the HIV incidence rate was flat for females aged 25–49 years, ranging from 4.14 (95% CI: 3.35–5.01) to 5.00 (95% CI: 4.37–5.69) events/100 person-years. ART coverage was significantly higher in woman, increasing from 28.3% to 43.6% between 2010 and 2013, when compared with men, which increased from 26.7% to 32.3%. Among woman aged 15–25 years, the virologic suppression level increased from 20.8% (95% CI: 16.5–25.2%) in 2011 to 40% (95% CI: 34.4-45.7%) in 2014. During this period, the virologic suppression level increased only slightly for men of the same age group, from 15.2% (95% CI: 5.8–24.7%) to 18.5% (95% CI: 7.8–29.2%).
The HIV incidence rate declined for all men aged 15–54 years between 2012 and 2015 but increased among young woman aged 15–25 years. We hypothesize that the more conscientious treatment-and-care behaviors of woman-i.e., higher ART uptake and higher rates of virologic suppression-has begun to protect men from acquiring HIV.
Alain Vandormael, Adam N Akullian, Adrian Dobra, Tulio de Oliveira, Frank Tanser
[link url="http://www.aidsmap.com/South-Africa-women-may-have-higher-rates-of-HIV-than-men-because-fewer-men-are-on-treatment/page/3249066/"]Aidsmap material[/link]
[link url="http://www.croiconference.org/sessions/sharp-decline-male-hiv-incidence-rural-south-african-population-2004–2015"]CROI 2018 abstract[/link]